EFIB 2021: Delivering the EU green deal
The European Forum for Industrial Biotechnology and Bioeconomy (EFIB) is Europe’s leading event for Industrial Biotechnology and the Bioeconomy. It provides a forum to discuss latest trends and advancements in the area of transformative bio-based technologies. Focus areas include circular bioeconomy and resource-efficiency approaches, innovative food and feed solutions, novel bio-based materials and textiles, sustainable urban living and architecture as well as environmental, financial and sustainability policy connected with the European Green Deal and the UN Sustainable Development Goals. (see the first program structure here)
In 2021, the two-day conference takes place from 5-7 October in Vienna, Austria. EFIB is proud to foster dialogue between policy makers and industry executives connected with the bio-based value chain and seeks to reach out to, and include, new interlocutors including from finance, science, and regulation. Around 400 experts are expected to join the 14th edition of the conference.
Under the main theme “Delivering the Green Deal: Industrial biotechnology into business”, the EFIB 2021 program features 10+ focused plenary and parallel tracks as well as roundtable sessions, attracting about 70+ speakers across the two main conference days. EFIB is proud to partner with LISAvienna for the 2021 edition. A pre-conference day on 5 October is scheduled to host dedicated workshops affiliated with the sector. It also provides the opportunity for local site visits to relevant stakeholders in industrial biotechnology and bioeconomy in and around Vienna. These are organized in cooperation with local partners.
One of the main topics of the conference will be Sustainable Living and the City of the Future, an issue where the Austrian capital is a leader. Agnes Borg, Director of Industrial Biotechnology at congress organizer EuropaBio in Brussels, said: “Vienna is a trailblazer when it comes to intelligent urban solutions, and it leads the way as far as sustainable technologies and innovation projects are concerned. The city is also home to around 500 life sciences companies. Furthermore, the capital’s start-up scene and numerous academic institutions show exactly what new technologies can contribute to the development of smarter cities.”
Foreseen to be one of the first in person conferences for the bio-based community in the second half of 2021, EFIB is expected to be among the first business and in person gatherings after a long time of event bans due to Covid-19 in Central Europe to offer 1-to-1 partnering with face-to-face meetings, an active exhibition onsite with a start-up village, a poster presentation area and the opportunity for stakeholders across the value chain to present their latest bio-based innovation and services – making it an unrivaled forum for companies across the bio-based industries sectors to meet, network and do business.